Medtronic plc (MDT) shares fell 0.1% to $93.75 as of September 16, 2026, a slight decline from the prior close of $93.80. BestStocks flagged the session as a major change for MDT. Below, we break down what changed for MDT, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
What happened
MDT fell 0.1% to $93.75
MDT fell 0.1% in its latest session, moving from $93.80 to $93.75.
ValuationWeak confidence
Rel. volume
0.8×
Below Avg
Vs peers
—
No comparable peers
Market cap
$120.0B
New York Stock Exchange
Analyst target
$98
+4.5% vs price
Price chart
Aug 17 – Sep 15
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details
What it means for Medtronic plc investors
For Medtronic plc investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Medtronic plc (MDT) moved +1.52% from $92.76 to $94.17 on 2026-09-04, reaching a new 30-day high; Positive price momentum. Weighing against that: Negative session, down 0.1%; Medtronic plc (MDT) moved -5.11% from $83.57 to $79.30 on 2026-07-14. Wall Street's consensus price target sits at $98.00, implying +4.5% upside from $93.75. Over the past 90 days analysts logged 1 upgrade and 0 downgrades. BestStocks rates the overall signal quality weak (25/100). With earnings roughly 62 days out, the next report is the most likely near-term test of the move.
MDT price reaction
MDT last traded at $93.75, down $0.05 (-0.05%) from the previous close of $93.80. The session traded on 0.8× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $89.97 and $94.17, and it currently sits about 90% of the way up that band.
Bullish and bearish analyst opinions on Medtronic plc (MDT)
The consensus analyst price target on Medtronic plc (MDT) is $98.00, 4.5% above the recent $93.75. Over the past 90 days analysts logged 1 upgrade, 14 maintains, and 0 downgrades. Here is how the bullish and bearish cases on MDT line up.
▲ The bullish case
+Wall Street's consensus price target of $98.00 implies +4.5% upside from $93.75.
+The Street's most bullish target is $115.00 (+22.7%).
+1 analyst upgrade in the past 90 days, most recently UBS to Buy (2026-07-28).
+Medtronic plc (MDT) moved +1.52% from $92.76 to $94.17 on 2026-09-04, reaching a new 30-day high.
+Positive price momentum.
▼ The bearish case
−The most bearish analyst target is $83.00 (-11.5%).
−Negative session, down 0.1%.
−Medtronic plc (MDT) moved -5.11% from $83.57 to $79.30 on 2026-07-14.
Bull vs bear balanceNeutral / Mixed
BearishNeutralBullish
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Sep 15, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Medtronic plc (MDT) moved +1.52% from $92.76 to $94.17 on 2026-09-04, reaching a new 30-day high. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
News2026-09-01+1.5%
Medtronic plc (MDT) moved −2.09% on 2026-09-01 despite reporting a fiscal first-quarter earnings beat with revenue of $9.756 billion, up 13.7% and above Wall Street expectations, while management raised its fiscal 2027 guidance. The company also announced strategic investments including a partnership with Cornerstone Robotics and an investment in Pi-Cardia.
Medtronic reported fiscal Q1 2027 earnings that beat expectations, with revenue of $9.756 billion (up 13.7% YoY) and adjusted EPS of $1.45, and raised full-year 2027 guidance (per finance.yahoo.com). The stock rose 2.41% to $92.83 on elevated volume of 9.4M shares (3.23x typical for this time of day), reflecting investor confidence in the earnings beat and forward outlook.
Medtronic rose 2.05% to $93.98 in intraday trading, outperforming a declining broader market (per Zacks report from 2026-08-18). Volume of 3.3 million shares ran at 0.56x the historical average for this time of day, suggesting below-average participation in the advance.
Medtronic shares rose 2.12% to $92.52 amid a sector-wide rebound in medical device stocks, buoyed by positive analyst sentiment and recent regulatory wins. Per the web_catalyst synthesis, major firms including BTIG and Citi maintain Buy ratings, while recent catalysts include Health Canada approval for the Affera heart rhythm system and momentum in pulsed field ablation and diabetes portfolios. Volume tracked at 0.64x expected intraday average, indicating below-average participation in the move.
Material / Earnings2026-08-14+0.8%
Medtronic plc (MDT) moved +0.31% from $90.99 to $91.27 on 2026-08-14, reaching a new 30-day high. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move appears to be technical, with volume near its 5-day average.
Material / Earnings2026-08-12+0.1%
Medtronic plc (MDT) moved +2.02% from $88.96 to $90.76 on August 12, 2026, reaching a new 30-day high. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average.
Material / Earnings2026-08-11+1.4%
Medtronic plc (MDT) moved +1.59% from $89.26 to $90.68 on 2026-08-11. We checked news, earnings announcements, analyst updates, filings, and corporate actions — no company-specific catalyst was found. The move appears to be driven by technical strength: MDT reached a new 30-day high with volume 1.5x the 5-day average.
Upcoming catalysts & outlook
Next earnings
2026-11-17 (est.)
in 62 days
10-K Annual Report (est.)
2027-06-18
Medium impact
Thesis shift
Neutral / Mixed
bearish signal
Risk level
Medium
from change events
Frequently asked questions about MDT
Why did Medtronic plc (MDT) stock move?
MDT fell 0.1% to $93.75. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did MDT stock fall?
MDT lost 0.05% ($0.05) versus the prior close of $93.80, last trading at $93.75 on 0.8× average volume.
When is Medtronic plc's next earnings date?
MDT's next earnings report is estimated for 2026-11-17 — about 62 days away.
What is the analyst price target for MDT?
The consensus analyst price target for MDT is $98.00, about 4.5% above the current $93.75. Over the past 90 days, analysts recorded 1 upgrade, 14 maintains, and 0 downgrades.
How BestStocks tracks MDT
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared MDT-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for MDT, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of September 16, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.
